Results 51 to 60 of about 1,194 (143)

Eczema Herpeticum in an Infant [PDF]

The Journal of Allergy and Clinical Immunology: In Practice, 2021
Guodong, Ding, Guifeng, Chen, Angela, Vinturache, Yongjun, Zhang, Zhongjie, Li   +4 more
openaire   +2 more sources

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, Volume 5, Issue 1, Page 67-74, March 2026.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source

Eczema Monkeypoxicum Following Sexual Transmission Treated With Tecovirimat

JEADV Clinical Practice, Volume 5, Issue 1, Page 250-253, March 2026.
Capsule summary Mpox is a zoonotic infection that may present severe dissemination in patients with pre‐existing dermatoses. We report a 30‐year‐old man with active atopic dermatitis who developed extensive, sexually transmitted mpox with widespread cutaneous involvement consistent with eczema monkeypoxicum.
Andrés Vidal González, Sergio López Alcázar, José Ángel Amat Sánchez, Francisco Vergara Barria, Rosa Feltes Ochoa, Elena Sendagorta Cudos, Pedro Herranz Pinto   +6 more
wiley   +1 more source

Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management

The Journal of Dermatology, Volume 53, Issue 3, Page 380-387, March 2026.
ABSTRACT The stratum corneum, as the outermost layer of the skin, functions as a critical barrier that maintains cutaneous hydration and systemic homeostasis. Among its structural lipids, ceramides constitute the most abundant and diverse component. These molecules are essential for the formation of lamellar structures that secure barrier integrity ...
Takashi Sakai
wiley   +1 more source

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory skin disease that markedly impairs quality of life. Janus kinase inhibitors (upadacitinib, abrocitinib, and baricitinib) are effective therapies for moderate‐to‐severe AD but are associated with viral reactivation, particularly herpes zoster (HZ), due to immunosuppressive effects on interferon ...
Anna Mandecka, Karolina Perlak, Wiktoria Bajek, Wiktor Kruczek, Aleksandra Frątczak, Karina Polak, Bartosz Miziołek, Beata Bergler‐Czop   +7 more
wiley   +1 more source

Kaposi′s varicelliform eruption: A case series

Indian Dermatology Online Journal, 2015
Kaposi's varicelliform eruption is a rare and potentially fatal viral infection caused mainly by reactivation of herpes simplex virus. It concomitantly occurs with pre-existing skin conditions, mostly atopic dermatitis, so it is predominately found in ...
Bruno Ferrari, Vanina Taliercio, Paula Luna, María Eugenia Abad, Margarita Larralde   +4 more
doaj   +1 more source

Severe generalized pustular psoriasis complicated with staphylococcal toxic shock syndrome treated with spesolimab and antibiotics

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Spyridon Gkalpakiotis, Jan Hugo, Natalie Michalik, Robert Zajicek, Cecilie Stonova, Bohumil Bakalar   +5 more
wiley   +1 more source

Efficacy and Safety of Oral JAK Inhibitors as Monotherapy in Moderate‐to‐Severe Atopic Dermatitis: A Systematic Review and Meta‐Analysis

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Janus kinase (JAK) inhibitors, as emerging drugs for the treatment of atopic dermatitis (AD), have demonstrated promising therapeutic potential. Objectives To evaluate the efficacy and safety of oral JAK inhibitors as monotherapy in moderate‐to‐severe AD.
XinWei Xie, LiLi Peng, AoQi Li, LiQiong Xu, Yu Tan, ChaoSheng Liu, Suraiya Saleem   +6 more
wiley   +1 more source

Comparative Safety Analysis of JAK Inhibitors in the Treatment of Atopic Dermatitis: Based on the FAERS Database

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Aim This study aimed to compare the safety profiles of abrocitinib, baricitinib, tofacitinib, and upadacitinib in the treatment of atopic dermatitis (AD) using adverse events (AEs) reported to the Food and Drug Adverse Event Reporting System (FAERS).
Zijun Song, Jianqin Yu, Hongyu Yang, Xinchang Xu, Aditya Gupta   +4 more
wiley   +1 more source

Contemporary Antiviral Drug Regimens for the Prevention and Treatment of Orolabial and Anogenital Herpes Simplex Virus Infection in the Normal Host: Four Approved Indications and 13 Off-Label Uses

Canadian Journal of Infectious Diseases, 2003
Herpes simplex virus (HSV) orolabial and anogenital infection causes substantial and recurring disease in healthy individuals due directly to infection of these sites and, indirectly, due to its complications.
Fred Y Aoki
doaj   +1 more source